Rick A. Bright

5.8k total citations · 4 hit papers
40 papers, 4.4k citations indexed

About

Rick A. Bright is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Rick A. Bright has authored 40 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 11 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Rick A. Bright's work include Influenza Virus Research Studies (31 papers), Respiratory viral infections research (22 papers) and Sepsis Diagnosis and Treatment (6 papers). Rick A. Bright is often cited by papers focused on Influenza Virus Research Studies (31 papers), Respiratory viral infections research (22 papers) and Sepsis Diagnosis and Treatment (6 papers). Rick A. Bright collaborates with scholars based in United States, China and France. Rick A. Bright's co-authors include Alexander Klimov, Nancy J. Cox, Xiyan Xu, Ted M. Ross, Teresa Wallis, Jacqueline M. Katz, Larisa V. Gubareva, Varough Deyde, Marie-jo Medina and Xiaohong M. Davis and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Rick A. Bright

40 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

2005 549 citations Rick A. Bright, Marie-jo Medina et al. The Lancet profile →
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States

2006 526 citations Rick A. Bright JAMA profile →
Transmission of Equine Influenza Virus to Dogs

2005 485 citations Iain Stephenson, Rick A. Bright et al. profile →
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018*

2020 177 citations Rick A. Bright et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rick A. Bright United States	23	3.5k	1.1k	1.0k	985	779	40	4.4k
Maki Kiso Japan	28	3.8k 1.1×	1.6k 1.4×	1.1k 1.1×	921 0.9×	953 1.2×	85	4.9k
Takato Odagiri Japan	37	2.8k 0.8×	1.0k 0.9×	968 1.0×	1.0k 1.0×	389 0.5×	132	3.9k
Larisa V. Gubareva United States	39	4.5k 1.3×	1.2k 1.1×	1.2k 1.2×	832 0.8×	602 0.8×	102	5.0k
Xiyan Xu United States	29	4.9k 1.4×	1.8k 1.6×	1.0k 1.0×	877 0.9×	1.7k 2.2×	60	5.4k
Larisa V. Gubareva United States	35	4.5k 1.3×	1.1k 1.0×	1.1k 1.1×	809 0.8×	414 0.5×	58	5.1k
Aeron C. Hurt Australia	44	4.9k 1.4×	1.7k 1.5×	1.2k 1.2×	1.1k 1.1×	1.0k 1.3×	136	6.1k
Rob Lambkin‐Williams United Kingdom	31	3.1k 0.9×	1.4k 1.2×	1.0k 1.0×	1.1k 1.1×	226 0.3×	74	4.5k
Yuelong Shu China	38	4.5k 1.3×	2.3k 2.0×	1.2k 1.1×	1.1k 1.1×	1.7k 2.2×	219	6.1k
Angie Lackenby United Kingdom	28	2.9k 0.8×	863 0.8×	693 0.7×	577 0.6×	292 0.4×	52	3.3k
Noel A. Roberts United Kingdom	20	2.2k 0.6×	1.2k 1.0×	830 0.8×	487 0.5×	344 0.4×	32	3.4k

Countries citing papers authored by Rick A. Bright

Since Specialization

Citations

This map shows the geographic impact of Rick A. Bright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick A. Bright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick A. Bright more than expected).

Fields of papers citing papers by Rick A. Bright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick A. Bright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick A. Bright. The network helps show where Rick A. Bright may publish in the future.

Co-authorship network of co-authors of Rick A. Bright

This figure shows the co-authorship network connecting the top 25 collaborators of Rick A. Bright. A scholar is included among the top collaborators of Rick A. Bright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick A. Bright. Rick A. Bright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bright, Rick A., et al.. (2024). Changing the culture of blood culture. The Lancet. 404(10462). 1503–1505. 2 indexed citations

Tromberg, Bruce J., Tara A. Schwetz, Eliseo J. Pérez‐Stable, et al.. (2020). Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative. New England Journal of Medicine. 383(11). 1071–1077. 143 indexed citations

Oshansky, Christine M., Yonghong Gao, Jo Ellen Schweinle, et al.. (2018). Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Vaccine. 37(3). 435–443. 17 indexed citations

Arabi, Yaseen M., Rob Fowler, Rick A. Bright, Maria D. Van Kerkhove, & Hanan H. Balkhy. (2016). Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome. The Lancet Respiratory Medicine. 4(2). 93–94. 1 indexed citations

Gessner, Bradford D., W. Abdullah Brooks, Kathleen M. Neuzil, et al.. (2013). Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30–December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine. 31(32). 3222–3228. 17 indexed citations

Wathen, Michael W., Mario Barro, & Rick A. Bright. (2012). Antivirals in seasonal and pandemic influenza—future perspectives^*. Influenza and Other Respiratory Viruses. 7(s1). 76–80. 26 indexed citations

Neuzil, Kathleen M., et al.. (2012). PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries. Expert Review of Vaccines. 11(8). 939–947. 7 indexed citations

Perdue, Michael L. & Rick A. Bright. (2011). United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Vaccine. 29. A48–A50. 9 indexed citations

Mochalova, Larisa V., Rick A. Bright, Xiyan Xu, et al.. (2010). Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconjugate Journal. 27(3). 321–327. 5 indexed citations

10.

Ross, Ted M., et al.. (2009). A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets. PLoS ONE. 4(6). e6032–e6032. 73 indexed citations

11.

Mahmood, Kutubuddin, Rick A. Bright, Nutan Mytle, et al.. (2008). H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine. 26(42). 5393–5399. 109 indexed citations

12.

Bright, Rick A., Donald M. Carter, Corey J. Crevar, et al.. (2008). Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle. PLoS ONE. 3(1). e1501–e1501. 204 indexed citations

13.

Sheu, Tiffany G., Varough Deyde, Margaret Okomo‐Adhiambo, et al.. (2008). Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy. 52(9). 3284–3292. 391 indexed citations

14.

Deyde, Varough, Xiyan Xu, Rick A. Bright, et al.. (2007). Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide. The Journal of Infectious Diseases. 196(2). 249–257. 441 indexed citations

15.

Hoelscher, Mary, Sanjay Garg, Dinesh S. Bangari, et al.. (2006). Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. The Lancet. 367(9509). 475–481. 160 indexed citations

16.

Shay, David K., Rick A. Bright, Michael W. Shaw, Nancy J. Cox, & Alexander Klimov. (2006). Shift Shown in Influenza A Adamantane Resistance—Reply. JAMA. 296(13). 1585–1585. 1 indexed citations

17.

Bright, Rick A., Marie-jo Medina, Xiyan Xu, et al.. (2005). Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. The Lancet. 366(9492). 1175–1181. 549 indexed citations breakdown →

18.

Rowe, Thomas, et al.. (2003). Neurological Manifestations of Avian Influenza Viruses in Mammals. Avian Diseases. 47(s3). 1122–1126. 23 indexed citations

19.

Bright, Rick A., Ted M. Ross, Kanta Subbarao, Harriet L. Robinson, & Jacqueline M. Katz. (2003). Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology. 308(2). 270–278. 55 indexed citations

20.

Ross, Ted M., Yan Xu, Rick A. Bright, & Harriet L. Robinson. (2000). C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunology. 1(2). 127–131. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact